He was the past chair of the Canadian Cardiovascular Society Heart Failure Guidelines Committee and continues working as a member of the Primary Panel of the Committee. His clinical research involves assessing the use of biomarkers, including B-type natriuretic peptides and new biomarkers in the management of acute and chronic heart failure and the quality of care in heart failure. Dr. Moe served in numerous industry-sponsored and investigator-initiated clinical trials as principal investigator. He authored multiple peer-reviewed journals and continues to serve on the editorial board of the Canadian Journal of Cardiology, Journal of American College of Cardiology, and American Heart Journal, to name a few. More recently, he created the first Cardiac Amyloidosis Clinic at St. Michael’s Hospital and begins to play a leadership role in managing this condition in Ontario with new research and knowledge translation. Dr. Moe is one of the recipients of the Queen’s Diamond Jubilee Medal, Queen Elizabeth II (Distinction), in 2012 for his dedicated service to peers, community, and Canada.